Myriad Genetics | MYGN - Текущие активы





Текущие активы Изменить Дата
Agilent USD 4.62B 21M 2025-12
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Bio-Rad Laboratories USD 2.94B 35.9M 2026-03
Bruker USD 2.1B 108.9M 2026-03
Danaher USD 13.94B 1.18B 2026-03
Illumina USD 2.74B 551M 2026-03
J&J USD 59.17B 3.55B 2026-03
Mettler Toledo International USD 1.33B 30.76M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
OraSure Technologies USD 240.78M 21.13M 2026-03
Pacific Biosciences Of California USD 369.52M 5.54M 2026-03
Quest Diagnostics USD 2.57B 188M 2026-03
Quidel USD 1.38B 70.3M 2026-03
Repligen USD 1.16B 23.98M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Standard Biotools USD 521.45M 67.19M 2026-03
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Veracyte USD 522.17M 33.8M 2026-03
Waters USD 3.72B 1.73B 2026-03